ASX:4DXHealthcare Services
A Look At 4DMedical (ASX:4DX) Valuation After CE Mark Milestone For CT:VQ In Europe
4DMedical (ASX:4DX) has attracted investor attention after its CT:VQ imaging technology secured CE Mark certification for commercial use in the European Union, with a rapid regional rollout now planned.
See our latest analysis for 4DMedical.
Investors have reacted strongly to the CE Mark news, with the A$6.80 share price reflecting a 55.25% 1 month share price return and a very large 1 year total shareholder return. This suggests momentum has been building rather than fading.
If CT based lung...